Cancer

News

US regulator grants fast review for AZ ovarian cancer drug

The US Food and Drug Administration (FDA) has granted AstraZeneca priority review for its ovarian cancer drug Lynparza – and the company has also revealed positive results for its diabetes

News

NICE rejects AZ's Lynparza tablets in ovarian cancer mainten...

AstraZeneca has said it will continue pricing negotiations with the NHS and NICE after the cost-effectiveness body said the tablet formulation of Lynparza (olaparib) is too expensive for re

News

BMS, AbbVie get FDA OK for new myeloma regimen

Bristol-Myers Squibb and AbbVie have picked up another FDA approval for their multiple myeloma drug Empliciti that they hope will help drive uptake of the drug.

News

Janssen J&J Johnson and Johnson pharmaceutical companies

J&J buys novel lung cancer drug from South Korea's Yuhan

Janssen Biotech has bought Yuhan’s Lazertinib, a novel clinical-stage therapeutic candidate for the treatment of patients with non-small cell lung cancer (NSCLC).

News

Blurred background for histopathology-related presentation. Stained histological tissue samples on glass, fixed tissue, automatic pipette and other work-related tools. Toned image, text space.

AI pathology project awarded £10.1m government funding

A digital pathology and artificial intelligence collaboration, with partners including Roche Diagnostics and Microsoft, has been awarded £10.1 million from a government-backed agency to exp

News

BMS and Infinity trial immunotherapy combo in bladder cancer

Bristol-Myers Squibb has broadened a collaboration with Infinity Pharmaceuticals as it seeks to find combinations that boost the potency of its cancer immunotherapy, Opdivo.

US regulator grants fast review for AZ ovarian cancer drug

NICE rejects AZ's Lynparza tablets in ovarian cancer mainten...

BMS, AbbVie get FDA OK for new myeloma regimen

J&J buys novel lung cancer drug from South Korea's Yuhan

AI pathology project awarded £10.1m government funding

BMS and Infinity trial immunotherapy combo in bladder cancer

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks